We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- Supply chain structure and actors
- Handling and transport for medicines
- Vulnerabilities and global disruptions
- Regulatory oversight and compliance
- Supply chain impact on patient health
- Need for resilience and transparency
Talk Citation
(2026, October 29). Pharmaceutical supply chain [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 29, 2026, from https://doi.org/10.69645/MKQE2950.Export Citation (RIS)
Publication History
- Published on October 29, 2026
Financial Disclosures
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
This overview addresses
pharmaceutical supply chain with
particular emphasis
on the structure and
actors involved in the global
pharmaceutical supply chain,
highlighting how
medicines travel
from raw materials to patients
through a network of suppliers,
manufacturers and distributors.
We will discuss the
complexities of
handling and transporting
sensitive medicines,
as well as the
vulnerabilities and
disruptions exposed by
recent global events.
The importance of stringent
regulatory oversight
and compliance will be examined,
along with how supply
chain reliability
affects patient health.
Finally, we will emphasize
the growing need for resilience,
transparency, and
collaboration in
ensuring continuous drug
availability worldwide.
We will explore the
pharmaceutical supply chain,
a vital web ensuring
lifesaving medicines
reach patients worldwide.
This global network includes
raw material suppliers,
manufacturers,
packagers, wholesalers,
logistics providers,
pharmacies, hospitals,
and regulators.
For example, a
tablet prescribed in
the United Kingdom may
have APIs from India,
be formulated in Germany,
packaged in Spain, and
distributed across the NHS.
This international system
boosts efficiency and savings,
but also adds complexity
and potential risk,
requiring robust
planning and oversight.
The pharmaceutical supply chain
is among the most
complex in any industry.
Medicines are sensitive
to temperature,
humidity, handling, and have
strict expiration dates.
Some, like vaccines
and biologics,